NIH launches clinical trials for long COVID; HHS office to coordinate federal response | AHA News – American Hospital Association

The National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER) Initiative opened enrollment for clinical trials to evaluate the safety and effectiveness of at least four potential treatments for Long COVID in adults. The project expects to launch trials to test at least seven more treatments in coming months, informed by findings from its other research over the past two years.
“Recognizing that more than one solution is likely needed, we’ve taken the lessons learned from RECOVER participants to design rigorous clinical trial platforms that will identify treatments for persons with different symptom clusters to improve their function and well-being,” said Walter Koroshetz, M.D., director of the NIH’s National Institute of Neurological Disorders and Stroke.
In related news, the Department of Health and Human Services today officially launched its Office of Long COVID Research and Practice to coordinate and lead the federal response to Long COVID.
Noncommercial use of original content on is granted to AHA Institutional Members, their employees and State, Regional and Metro Hospital Associations unless otherwise indicated. AHA does not claim ownership of any content, including content incorporated by permission into AHA produced materials, created by any third party and cannot grant permission to use, distribute or otherwise reproduce such third party content. To request permission to reproduce AHA content, please click here.


Leave a Reply

Your email address will not be published. Required fields are marked *